XTLB Stock Analysis: Buy, Sell, or Hold?
XTLB - XTL Biopharmaceuticals Ltd. American Depositary Shares
$2.90
-0.08 (-2.68%)
▼
5d:
+6.23%
30d:
+40.78%
90d:
+21.85%
HOLD
MODERATE Confidence
Analysis Updated: Jul 8, 2026 12:00 AM ET
Earnings: Apr 29, 2026
0d
Get Alerted When XTLB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: XTLB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: XTLB shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: XTLB is currently trading at $2.90, which is considered extended relative to its 30-day fair value range of $2.22 to $2.76.
Technical Outlook: Technically, XTLB is in a strong uptrend. The price is approaching resistance at $2.59. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: XTLB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.00 (+934.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, XTLB is in a strong uptrend. The price is approaching resistance at $2.59. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: XTLB has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $30.00 (+934.5%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.22 -
$2.76
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BEARISH: Price extended above range (+5.1% above its trading range)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 934.5% below Wall St target ($30.00)
Trading Range Analysis
30-Day Trading Range
$2.22 -
$2.76
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.01
Resistance Level
$2.59
Current Trend
Strong Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Wall Street Target
$30.00
(+934.5%)
Earnings Growth (YoY)
-76.0%
Share & Embed Analysis
Last updated: July 09, 2026 6:24 AM ET
Data refreshes hourly during market hours. Next update: 7:24 AM
Data refreshes hourly during market hours. Next update: 7:24 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XTLB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 58 HOLD |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$833 | 63 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 55 HOLD |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 56 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 59 HOLD |